Altered expression of genes for Kir ion channels in dilated cardiomyopathy

Viktoria Szuts1, Dalma Ménesi, Zoltán Varga-Orvos

  • 1Institute of Biochemistry, Biological Research Centre, Hungarian Academy of Sciences, Szeged, Hungary.

Insights

Gene expression of Kir2.x potassium channels and SAP97 changes in dilated cardiomyopathy (DCM). Healthy hearts show high KCNJ2, KCNJ12, KCNJ4, and low KCNJ14. DCM alters Kir2.1, Kir2.3, Kir2.2, and DLG1 expression.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Genetics

Background:

  • Dilated cardiomyopathy (DCM) is a complex heart condition affecting the left ventricle.
  • Cardiac muscle repolarization involves Kir2.x potassium channels, crucial for electrical stability.

Purpose of the Study:

  • To investigate gene expression changes of Kir2.x channels and SAP97 in healthy versus DCM human hearts.
  • To understand the molecular basis of electrical and functional alterations in DCM.

Main Methods:

  • Analysis of KCNJ gene (encoding Kir2.x channels) and DLG1 (encoding SAP97) expression in human ventricular tissue.
  • Comparison of gene expression profiles between healthy and DCM hearts across different age groups.

Main Results:

  • In healthy hearts, KCNJ2, KCNJ12, KCNJ4 were highly expressed, while KCNJ14 was low.
  • DCM hearts showed upregulated Kir2.1 and Kir2.3, and downregulated Kir2.2 channel expression.
  • DLG1/SAP97 expression decreased with age in normal hearts and was significantly reduced in young DCM patients.

Conclusions:

  • Altered expression of Kir2.x channels and SAP97 in DCM suggests a role in disease pathophysiology.
  • These molecular changes may contribute to the observed electrical and mechanical dysfunction in dilated cardiomyopathy.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...